Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer

Lignende værker

• Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
  af: Slevin, Finbar, et al.
  Udgivet: (2020)
• Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
  af: Yamazaki, Hideya, et al.
  Udgivet: (2021)
• Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
  af: Ota, Yoshiaki, et al.
  Udgivet: (2020)
• High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
  af: Yamazaki, Hideya, et al.
  Udgivet: (2021)
• The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
  af: Yoshioka, Yasuo, et al.
  Udgivet: (2013)